Nice but18 Dec 2020 09:36
All I read from the RNS is that due to the failure to attract enough volunteers, the target has been reduced. The share price increase of around 25% is surprising and if not today, could well go back tomorrow. As have said before, if I had Covid related lung/breathing issues but not in hospital, then it is probably not that debilitating and so why would I want to be a guinea pig (with the risk of the dratted Placebo) when I would probably get better in any case. Its the hospitals that need to take on these trials so I must ask the question, why aren't they?